Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Allergic; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of allergic reaction in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced allergic reaction (Verbatim: Allergic). The outcome of the allergic reaction was unknown. The reporter considered the allergic reaction to be related to Shingrix. The company considered the allergic reaction to be related to Shingrix. Additional Information: GSK Receipt Date: 14-SEP-2025 and 25-SEP-2025 This case was reported by a patient via interactive digital media. The patient received the vaccine shot and had an allergic reaction. The doctor advised the patient not to receive the second dose of the (Shingrix) shingles vaccine. The batch number was not provided, and we are unable to contact the reporter.